Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5464)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2013 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Suda T, Nagashima A, Takahashi S, Kanefuji T, Kamimura K, Tamura Y, Takamura M, Igarashi M, Kawai H, Yamagiwa S, Nomoto M, Aoyagi Y. Active treatments are a rational approach for hepatocellular carcinoma in elderly patients. World J Gastroenterol 2013; 19(24): 3831-3840 [PMID: 23840122 DOI: 10.3748/wjg.v19.i24.3831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i24/3831.htm |
| Number | Citing Articles |
| 1 |
Kenya Kamimura, Akira Sakamaki, Hiroteru Kamimura, Toru Setsu, Takeshi Yokoo, Masaaki Takamura, Shuji Terai. Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients. World Journal of Gastroenterology 2019; 25(15): 1817-1827 doi: 10.3748/wjg.v25.i15.1817
|
| 2 |
TOMOYUKI NEMOTO, HIDETAKA MATSUDA, TAKUTO NOSAKA, YASUSHI SAITO, YOSHIHIKO OZAKI, RYOKO HAYAMA, TATSUSHI NAITO, KAZUTO TAKAHASHI, KAZUYA OFUJI, MASAHIRO OHTANI, KATSUSHI HIRAMATSU, HIROYUKI SUTO, YASUNARI NAKAMOTO. Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series. Molecular and Clinical Oncology 2014; 2(6): 1028 doi: 10.3892/mco.2014.371
|
| 3 |
Akiyoshi Kinoshita, Kazuhiko Koike, Hirokazu Nishino. Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection. Geriatrics & Gerontology International 2017; 17(2): 189 doi: 10.1111/ggi.12747
|
| 4 |
Ling-Yun Zhao, Rong-Rui Huo, Xiao Xiang, Guido Torzilli, Ming-Hua Zheng, Tian Yang, Xin-Min Liang, Xi Huang, Pei-Ling Tang, Bang-De Xiang, Le-Qun Li, Xue-Mei You, Jian-Hong Zhong. Hepatic resection for elderly patients with hepatocellular carcinoma: a systematic review of more than 17,000 patients. Expert Review of Gastroenterology & Hepatology 2018; 12(10): 1059 doi: 10.1080/17474124.2018.1517045
|
| 5 |
Giuseppe Cabibbo, Marcello Maida, Calogero Cammà, Antonio Craxì. Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?. Expert Review of Anticancer Therapy 2013; 13(12): 1355 doi: 10.1586/14737140.2013.859989
|
| 6 |
Hiroya Iida, Masaki Kaibori, Kosuke Matsui, Morihiko Ishizaki, Masanori Kon. Assessing the feasibility of clinicopathological features of hepatic resection for hepatocellular carcinoma in patients over 80 years of age. Molecular and Clinical Oncology 2017; 6(1): 29 doi: 10.3892/mco.2016.1079
|
| 7 |
Maisa Hori, Masatoshi Tanaka, Eiji Ando, Masahiro Sakata, Shigeo Shimose, Miki Ohno, Shigeru Yutani, Kei Kuraoka, Ryoko Kuromatsu, Shuji Sumie, Michio Sata. Long‐term outcome of elderly patients (75 years or older) with hepatocellular carcinoma. Hepatology Research 2014; 44(9): 975 doi: 10.1111/hepr.12279
|
| 8 |
Kevin Ka Wan Chu, Kenneth Siu Ho Chok. Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?. World Journal of Gastroenterology 2019; 25(27): 3563-3571 doi: 10.3748/wjg.v25.i27.3563
|
| 9 |
Hao Zhou, Junhong Chen, Kai Liu, Hongji Xu. Prognostic factors and predictive nomogram models for early death in elderly patients with hepatocellular carcinoma: a population-based study. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1275791
|